Thursday | Friday | Saturday | sunday

(Schedule is subject to change)

Thursday, August 24, 2023

8:15 a.m. – 8:45 a.m. 


8:45 a.m. – 9:35 a.m. 

Welcome Announcements and ASCO DirectTM Highlights Breast
Speaker: Cynthia Lynch, MD, Medical Oncologist, City of Hope Phoenix

This session will discuss breast cancer updates from ASCO as well as recent developments in treating metastatic breast cancer and triple negative breast cancer.

9:40 a.m. – 10:25 a.m. 

ASCO DirectTM Highlights Gastrointestinal
Speaker: Eric Chen, MD, Staff Physician, Princess Margaret Cancer Center 
CME: 0.75 

Review latest results in the treatment of gastrointestinal cancers.

10:30 a.m. – 11:00 a.m. 

Refreshment Break With Exhibitors

11:00 a.m. – 11:45 a.m. 

ASCO DirectTM Highlights Genitourinary
Speaker: Laura Graham, MD, Assistant Professor of Medical Oncology, University of Colorado
CME: 0.75

Review of practice changing abstracts from ASCO and GU ASCO with focus on emerging therapeutic strategies for GU malignancies. 

11:50 a.m. – 12:35 p.m.

ASCO DirectTM Highlights Lung
Speaker: Robert Galamaga, DO, MS, Hematologist/Medical Oncologist, City of Hope/CTCA
CME: 0.75

High yield review of practice-changing developments in the thoracic oncology space.

12:40 p.m. – 1:40 p.m.

Non-CME Product Theater Lunch supported by

Practical Management AML with a BCL-2 Inhibitor
Speakers: Vincent Vidaurri, AbbVie Oncology Senior MSL; Justin Hayne, AbbVie Oncology Senior II MSL; and Evgeny Mikler, AbbVie Oncology MSL

1:40 p.m. – 2:30 p.m.

ASCO DirectTM Highlights Head and Neck
Speaker: Andrew Hope, MD, Clinician Investigator/Associate Professor, University Health Network
CME: 0.75

Dr. Hope will review the important presentations at ASCO 2023 focused on the topic of Head and Neck cancer management.

2:35 p.m.  3:25 p.m. 

ASCO DirectTM Highlights Gynecologic Malignancies
Speaker: Karina Nieto, MD, Director of Brachytherapy, Assistant Professor, University Hospitals, Case Western
CME: 0.75

This session will discuss the latest updates in gynecologic malignancies with treatment using evidence based medicine.

3:25 p.m. – 3:55 p.m.

Refreshment Break With Exhibitors

3:55 p.m. – 4:45 p.m.

Panel Discussion - Professional Development: Charting Your Path Forward
Moderator: Jeremy Heinrich, PA-C, DFAAPA, Clinical Director, Mount Sinai Hospital
Panelists: Maitry Patel, MBA, CCPA, Manager, Clinical Operations, University Hospitals; Risa Zimmerman, MBA,MPAS, PA-C, DFAAPA, Director, Office of Advanced Practice, Nebraska Medicine; Alanne Conrad, DMSC, MSPAS, PA-C, Director of Clinical Education, Colorado Mesa University; Laura Peters, DNP, FNP-C, Nurse Practitioner, University of Colorado; and John Katsetos, PA-C, Sr. Medical Science Liaison, Stemline
CME: 0.75

Moderated by Jeremy Heinrich, this panel discussion with focus on how PAs can advance professionally in a variety of different areas such as pharma, MSL, IT, business, education, and research. Different Industry leaders will share their journeys and discuss opportunities for PAs.

4:45 p.m. – 4:55 p.m.

Closing Announcements

5:15 p.m. – 6:15 p.m.

Wine and Cheese Reception and Poster Presentations Supported by

CME: 1.00


Friday, August 25, 2023

8:15 a.m. – 8:45 a.m.


8:45 a.m. – 9:55 a.m.

Welcome Announcements and Keynote Speaker: Finding a Way: Taking the Impossible and Making It Possible
Speaker: Siri Lindley, High Performance Coach, Sirius Athletes Inc
CME: 1.00

Siri will share her story of resilience - how she found a way through harrowing challenges and achieved what seemed impossible. Siri will share the tools on how you, too, can find a way and thrive through challenges through sharing her story.

10:00 a.m. – 10:35 a.m. 

Membership/State of APAO
Speaker: Tiffany Statler, PA-C, APAO President
CME: 0.50

10:40 a.m. – 11:10 a.m.

Refreshment Break With Exhibitors

11:10 a.m. – 12:30 p.m. 

Practical Tips in Building an Oncology Survivorship Program
Speaker: Keri Halsema, NP, Nurse Practitioner, University of Colorado, Blood Disorders Center
CME: 1.25

This session will feature a review of key operational and clinical building blocks in the creation of a robust oncology survivorship program.

12:30 p.m. – 1:30 p.m.

Non-CME Product Theater Lunch supported by

The FIRST and ONLY Therapy Approved for Adults With Indolent Systemic Mastocytosis (ISM)
Salman Fazal, MD, Director, Cell Transplantation Program, Allegheny Health Network Cancer Institute

1:30 p.m. – 2:00 p.m. 

Networking Roundtable Discussions (Non-CME)

2:00 p.m. – 2:45 p.m. 

ASCO DirectTM Highlights Lymphoma
Speaker: Brad Haverkos, MD, Associate Professor, University of Colorado
CME: 0.75

This talk will briefly review the most recent updates in the management of indolent and aggressive lymphomas.

2:50 p.m. – 3:20 p.m. 

Refreshment Break With Exhibitors

3:25 p.m. – 4:10 p.m. 

ASCO DirectTM Highlights Leukemia
Speaker: Jonathan Gutman, MD, Professor, Director of Stem Cell Transplant and Cellular Therapy, University of Colorado
CME: 0.75

This session will review practice-changing and other top abstracts from ASCO 2023 in Leukemia and MDS.

4:15 p.m. – 5:00 p.m. 

ASCO DirectTM Highlights Myeloma
Speaker: Jeff Schriber, MD, Director Heme Malignancies, COH PHX
CME: 0.75

This session will offer a review of current thinking on MM with highlights of ASCO.

5:05 p.m. – 5:10 p.m. 

Closing Announcements

6:00 p.m. – 9:00 p.m. 

Welcome Reception


Saturday, August 26, 2023

8:15 a.m. – 8:45 a.m.


8:45 a.m. – 8:55 a.m.

Welcome Announcements

8:55 a.m. – 9:45 a.m. 

The Hill We Must Climb: Addressing Disparities in Academic Medicine
Speaker: Danielle Rodin, MD, MPH, FRCPC, Radiation Oncologist, Princess Margaret Cancer Centre
CME: 0.75

Delivering excellent and equitable cancer care requires the identification, acknowledgement, and proactive mitigation of biases in academic medical centers. This session will explore the impact of these biases on clinical outcomes and on provider well-being, and how organizations can take a proactive stance to promote workforce equity, organizational culture, and better care for our patients.

8:55 a.m. – 9:45 a.m.  

Cancer-Associated Thrombosis: Risk factors, Prevention, and Management
Speaker: Brandon McMahon, MD, Associate Professor of Medicine, University of Colorado
CME: 0.75


9:50 a.m. – 10:40 a.m. 

Interventional GI: Cryoablation in Esophageal Cancer
Speaker: Youssef Soliman, MD, Gastroenterologist, City of Hope Phoenix
CME: 0.75

Cancer treatment is multifaceted. A recurring focus involves optimizing treatment with quality of life. Dysphagia from esophageal cancer can be debilitating. In cases that are not good candidates for surgical resection, palliative endoscopic options exist. One of these options is tumor debulking by cryotherapy. Increasingly, reports show positive results that are promising to improve patient quality of life.

9:50 a.m. – 10:40 a.m. 

Personalized Approach to Patients With Myeloproliferative Neoplasms (MPNs)
Speaker: Lindsey Lyle, MS, PA-C, Physician Assistant, Denver, Colorado
CME: 0.75

This session will provide a generalized overview of the various subtypes of myeloproliferative neoplasms, review diagnostic and prognostic criteria, and encourage PAs to personalize approach to treatment.

10:40 a.m. – 11:20 a.m. 

Refreshment Break

11:20 a.m. – 12:10 p.m. 

All About Brain Metastases
Speaker: Maitry Patel, MBA, CCPA, Manager, Clinical Operations, University Hospitals
CME: 0.75

Brain Metastases are increasing in incidence since systemic tumor therapies have improved, resulting in longer patient survival, better control of metastases in distant organs and also due to better diagnostic techniques. We will discuss epidemiology, therapeutic options and novel therapies, including role of supportive care in this talk.

11:20 a.m. – 12:10 p.m. 

Team Based Care in Genetic Counseling
Speakers: Alisha DeTroye, MMS, PA-C, DFAAPA, Regional Director of Advanced Practice, Atrium Health Wake Forest Baptist-Advocate Health; and Thuy Vu, CGC, Genetic Counselor, Atrium Health Wake Forest Baptist
CME: 0.75

An Oncology PA and Certified Genetic Counselor review key strategies for identifying patients at risk for cancer genetic syndromes, how to maximize your referrals and collaborate on high risk patients.

12:10 p.m. – 1:10 p.m. 

Non-CME Product Theater Lunch supported by


Polycythemia Vera Clinical Case Discussion: When to Intervene with Jakafi® (ruxolitinib)
Speaker: Lindsey Lyle, MS, PA-C 

1:30 p.m. – 2:20 p.m. 

Unveiling Breakthroughs: Recent Approvals in Solid Tumors
Speaker: Khurrum Qureshi, PharmD, Clinical Pharmacy Specialist, Miami Cancer Institute/Baptist Health South Florida
CME: 0.75

This session will review recent approvals of new medications indicated in solid tumor disease states. The review will focus on clinical efficacy and safety, dosing considerations, and management strategies of associated toxicities.

1:30 p.m. – 2:20 p.m. 

New Drugs - Hematologic Malignancies
Speaker: Jennifer Tobin, PharmD, Clinical Pharmacy Specialist, UCHealth
CME: 0.75

This session will offer a review of all pertinent new agent approvals in late 2022 and early 2023 for hematologic malignancies. The review will consist of mechanism of action, dosing, drug interactions, and side effect management.

2:25 p.m. – 3:15 p.m.

Bone Marrow Biopsy – Bedside to Basepair  Mastering the Art of Science
Speaker: Aamir Ehsan, MD, Hematopathologist/Molecular Geneticist and Medical Director, CorePath Laboratories
CME: 0.75

This session will review the common tests sent from a bone marrow, discuss the terminology used in reports and their significance, and review sample comprehensive hematopathology reports.

3:15 p.m. – 3:20 p.m. 

Closing Remarks

3:20 p.m. – 5:20 p.m. 

Bone Marrow and Lumbar Puncture Workshop
Speakers: Keri Halsema, NP, Nurse Practitioner, University of Colorado, Blood Disorders Center; Jeremy Heinrich, PA-C, DFAAPA, Clinical Director, Mount Sinai Hospital; and Nicholas Birdsey, PA-C, Instructor, University of Colorado
CME: 2

In this workshop attendees will:

1. Understand the indications and procedural steps to perform bone marrow biopsies and lumbar punctures;
2. Recognize common adverse events associated with bone marrow biopsies and lumbar punctures; and
3. Perform bone marrow biopsies and lumbar punctures on models.

3:20 p.m. – 5:20 p.m. 

Elevating Your Voice! From the Elevator to the Board Room
Speakers: Risa Zimmerman, MBA, MPAS, PA-C, DFAAPA, Director, Office of Advanced Practice, Nebraska Medicine; and Alisha DeTroye, MMS, PA-C, DFAAPA, Regional Director of Advanced Practice, Atrium Health Wake Forest Baptist-Advocate Health
CME: 2.00

An interactive, fun workshop to help you develop your brand and ease your anxiety with public speaking. Whether it is your next elevator pitch, clinical proposal, or podium presentation, we want it to be a success!


Sunday, August 27, 2023

7:45 a.m. – 8:10 a.m. 


8:10 a.m. – 9:05 a.m. 

Welcome Announcements and Pearls For Opioid Management from a Palliative Care Physician
Speaker: Carl Grey, MD, Enterprise Director of Hospice and Palliative Care, Atrium Health Wake Forest
CME: 0.75

In this session, Dr. Grey will:

1. Review opioid management strategies for cancer patients including starting doses and titration schedule of short-acting agents;
2. Discuss opioid modifications based on liver or renal impairment;
3. Review how to initiate long-acting opioid management and titration; and
4. Discuss incomplete cross-tolerance when switching to a new opioid.

9:10 a.m. – 10:00 a.m. 

Medical Aid in Dying: Ethical and Practical Issues
Speaker: Jonathan Treem, MD, Assistant Professor, University of Colorado School of Medicine
CME: 0.75 

Dr. Treem will give an overview of the current legal, ethical, and clinical framework for medical-aid-in-dying in the US.

10:00 a.m. – 10:10 a.m. 

Stretch Break

10:10 a.m. – 11:00 a.m.

Immune Effector Cell Therapy Updates: CAR-T Cells Are Driving the Field
Speaker: M. Heather Knowles, PhD, PA-C, APP Associate Director of Cell Therapy, Assistant Professor, University of Colorado, Blood Disorders & Cell Therapy Center
CME: 0.75

This session will offer an overview of the different types of immune effector cell therapies and how they are used to eliminate cancer. We will discuss the mechanisms of action, FDA indications and highlight some of the unique toxicities associated with these powerful therapies.

11:05 a.m. – 11:50 a.m.

Cardio-Oncology: Treating the Heart of Cancer Patients
Speaker: Peter Kim, MD, Cardiologist, MD Anderson Cancer Center
CME: 0.75

This session will review the basics of cardio-oncology focusing on the diagnosis, treatment, and prevention of cardiac disease in cancer patients.

11:55 a.m. – 12:00 p.m.

Closing Announcements